Singapore Research Network Named WHO Collaborating Centre to Boost Regional Health

2026-09-04

A prominent Singapore research network has been officially appointed as a World Health Organization (WHO) collaborating centre. This new role focuses on strengthening the capacity for clinical trials across the region, marking a significant step forward for medical research in Southeast Asia.

Clinical trials are essential in the medical field because they provide the evidence needed to improve patient care. By testing new treatments, researchers can ensure that medicines and vaccines are both safe and effective before they are used by the general public. These trials also play a vital role in informing government health policies.

As a WHO collaborating centre, the Singapore network will work closely with international experts to share knowledge and best practices. This partnership aims to standardize how clinical trials are conducted, making it easier for countries in the region to develop and approve life-saving medical solutions more quickly.

This appointment highlights Singapore’s growing reputation as a hub for medical innovation and scientific excellence. By leading these efforts, the city-state will play a key role in improving health outcomes not just for its own citizens, but for millions of people throughout the region.